Journal Logo

November 2001 - Volume 29 - Issue 11
pp: 2045-2237

Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis

Bernard, Gordon R.; Ely, E. Wesley; Wright, Theressa J.; More

Critical Care Medicine. 29(11):2051-2059, November 2001.

Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study

Abraham, Edward; Reinhart, Konrad; Svoboda, Petr; More

Critical Care Medicine. 29(11):2081-2089, November 2001.

Compliance with triage to intensive care recommendations

Azoulay, Élie; Pochard, Frédéric; Chevret, Sylvie; More

Critical Care Medicine. 29(11):2132-2136, November 2001.